DAVID SPANGLER

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · WASHINGTON, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

last 3 years

Filings

6 agencies contacted

Activity

filings by quarter

Works on

Consumer Issues/Safety/Products 5 Health Issues 5 Manufacturing 5 Pharmacy 5 Taxation/Internal Revenue Code 5

Background

Career

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

WASHINGTON, DC

2024 - present

Specific issues

- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)

Taxation/Internal Revenue Code · 2025 Q1

- Pharmaceutical Tariffs

Manufacturing · 2025 Q1

- Reauthorization of the Over the Counter Monograph User Fee Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - FDA Modernization Act 3.0

Health Issues · 2025 Q1

- The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act

Pharmacy · 2025 Q1

H.R. 4794 - Dietary Supplement Access Act H.R. 8599 - Oral Care Products Inclusion Act

Taxation/Internal Revenue Code · 2024 Q4

H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023 Office of the US Trade Representative 2024 Review of Notorious Markets for Counterfeiting and Piracy: Comment Request; Request for comments

Consumer Issues/Safety/Products · 2024 Q4